Erratum to: Evaluation of S-1 as third- or further-line chemotherapy in advanced non-small-cell lung cancer

被引：0
|
作者：
Akira Ono
Tateaki Naito
Haruyasu Murakami
Toshiaki Takahashi
Yukiko Nakamura
Asuka Tsuya
Kyoichi Kaira
Satoshi Igawa
Takehito Shukuya
Akihiro Tamiya
Rieko Kaira
Masahiro Endo
Nobuyuki Yamamoto
机构：
[1] Shizuoka Cancer Center,Division of Thoracic Oncology
[2] Shizuoka Cancer Center,Division of Diagnostic Radiology
来源：
International Journal of Clinical Oncology | 2010年 / 15卷
关键词：
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：331 / 331
相关论文
共 50 条
  • [1] Evaluation of S-1 as third- or further-line chemotherapy in advanced non-small-cell lung cancer
    Akira Ono
    Tateaki Naito
    Haruyasu Murakami
    Toshiaki Takahashi
    Yukiko Nakamura
    Asuka Tsuya
    Kyoichi Kaira
    Satoshi Igawa
    Takehiro Shukuya
    Akihiro Tamiya
    Rieko Kaira
    Masahiro Endo
    Nobuyuki Yamamoto
    [J]. International Journal of Clinical Oncology, 2010, 15 : 161 - 165
  • [2] Evaluation of S-1 as third- or further-line chemotherapy in advanced non-small-cell lung cancer
    Ono, Akira
    Naito, Tateaki
    Murakami, Haruyasu
    Takahashi, Toshiaki
    Nakamura, Yukiko
    Tsuya, Asuka
    Kaira, Kyoichi
    Igawa, Satoshi
    Shukuya, Takehiro
    Tamiya, Akihiro
    Kaira, Rieko
    Endo, Masahiro
    Yamamoto, Nobuyuki
    [J]. INTERNATIONAL JOURNAL OF CLINICAL ONCOLOGY, 2010, 15 (02) : 161 - 165
  • [3] Evaluation of S-1 as third- or further-line chemotherapy in advanced non-small-cell lung cancer (vol 15, pg 161, 2010)
    Ono, Akira
    Naito, Tateaki
    Murakami, Haruyasu
    Takahashi, Toshiaki
    Nakamura, Yukiko
    Tsuya, Asuka
    Kaira, Kyoichi
    Igawa, Satoshi
    Shukuya, Takehito
    Tamiya, Akihiro
    Kaira, Rieko
    Endo, Masahiro
    Yamamoto, Nobuyuki
    [J]. INTERNATIONAL JOURNAL OF CLINICAL ONCOLOGY, 2010, 15 (03) : 331 - 331
  • [4] Third- and further-line therapy in advanced non-small-cell lung cancer patients: an overview
    Genestreti, Giovenzio
    Grossi, Francesco
    Genova, Carlo
    Burgio, Marco A.
    Bongiovanni, Alberto
    Gavelli, Giampaolo
    Bartolotti, Marco
    Di Battista, Monica
    Cavallo, Giovanna
    Brandes, Alba A.
    [J]. FUTURE ONCOLOGY, 2014, 10 (13) : 2081 - 2096
  • [5] Efficacy of Vinorelbine Monotherapy as Third- or Further-Line Therapy in Patients with Advanced Non-Small-Cell Lung Cancer
    Kang, Hyun
    Kim, Ju Ock
    Jung, Sung Soo
    Park, Hee Sun
    Chung, Chaeuk
    Park, Dongil
    Lee, Jeong Eun
    [J]. ONCOLOGY, 2019, 97 (06) : 356 - 364
  • [6] Phase II trial of S-1 as third-line or further chemotherapy in patients with advanced non-small-cell lung cancer
    Miyoshi, Seigo
    Ito, Ryoji
    Katayama, Hitoshi
    Kadowaki, Toru
    Yano, Shuichi
    Watanabe, Akira
    Abe, Masahiro
    Hamada, Hironobu
    Okura, Takafumi
    Higaki, Jitsuo
    [J]. INTERNATIONAL JOURNAL OF CLINICAL ONCOLOGY, 2014, 19 (06) : 1005 - 1010
  • [7] Phase II trial of S-1 as third-line or further chemotherapy in patients with advanced non-small-cell lung cancer
    Seigo Miyoshi
    Ryoji Ito
    Hitoshi Katayama
    Toru Kadowaki
    Shuichi Yano
    Akira Watanabe
    Masahiro Abe
    Hironobu Hamada
    Takafumi Okura
    Jitsuo Higaki
    [J]. International Journal of Clinical Oncology, 2014, 19 : 1005 - 1010
  • [8] Irinotecan monotherapy as third- or further-line treatment for patients with small cell lung cancer
    Seto, Zenta
    Takata, Naoki
    Murayama, Nozomu
    Tokui, Kotaro
    Okazawa, Seisuke
    Kambara, Kenta
    Imanishi, Shingo
    Miwa, Toshiro
    Hayashi, Ryuji
    Matsui, Shoko
    Inomata, Minehiko
    [J]. TUMORI JOURNAL, 2021, 107 (06): : 536 - 541
  • [9] Clinical outcome of ifosfamide in combination with carboplatin in small cell lung cancer: Results from third- or further-line chemotherapy
    Park, M.
    Lee, J.
    [J]. ANNALS OF ONCOLOGY, 2017, 28
  • [10] The Efficacy and Safety of Anlotinib Combined With PD-1 Antibody for Third-Line or Further-Line Treatment of Patients With Advanced Non-Small-Cell Lung Cancer
    Zhai, Chongya
    Zhang, Xiaoling
    Ren, Lulu
    You, Liangkun
    Pan, Qin
    Pan, Hongming
    Han, Weidong
    [J]. FRONTIERS IN ONCOLOGY, 2021, 10
12345